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Jugesh I. Cheema, M.D., Richard G. Obregon, M.D., Jeff L. Fidler, M.D., Peter Zimmerman, M.D.,
Karen M. Horton, M.D., Kevin Coakley, M.D., Revathy B. Iyer, M.D., Amy K. Hara, M.D.,
Robert A. Halvorsen, Jr., M.D., Giovanna Casola, M.D., Judy Yee, M.D., Benjamin A. Herman, S.M.,
Lawrence J. Burgart, M.D., and Paul J. Limburg, M.D., M.P.H.

A bs t r ac t
Background

Computed tomographic (CT) colonography is a noninvasive option in screening for
colorectal cancer. However, its accuracy as a screening tool in asymptomatic adults
has not been well defined.
Methods

We recruited 2600 asymptomatic study participants, 50 years of age or older, at 15
study centers. CT colonographic images were acquired with the use of standard bowel
preparation, stool and fluid tagging, mechanical insufflation, and multidetector-row
CT scanners (with 16 or more rows). Radiologists trained in CT colonography reported
all lesions measuring 5 mm or more in diameter. Optical colonoscopy and histologic review were performed according to established clinical protocols at each
center and served as the reference standard. The primary end point was detection by
CT colonography of histologically confirmed large adenomas and adenocarcinomas
(10 mm in diameter or larger) that had been detected by colonoscopy; detection of
smaller colorectal lesions (6 to 9 mm in diameter) was also evaluated.
Results

Complete data were available for 2531 participants (97%). For large adenomas and
cancers, the mean (±SE) per-patient estimates of the sensitivity, specificity, positive
and negative predictive values, and area under the receiver-operating-characteristic
curve for CT colonography were 0.90±0.03, 0.86±0.02, 0.23±0.02, 0.99±<0.01, and
0.89±0.02, respectively. The sensitivity of 0.90 (i.e., 90%) indicates that CT colonography
failed to detect a lesion measuring 10 mm or more in diameter in 10% of patients. The
per-polyp sensitivity for large adenomas or cancers was 0.84±0.04. The per-patient
sensitivity for detecting adenomas that were 6 mm or more in diameter was 0.78.
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Conclusions

In this study of asymptomatic adults, CT colonographic screening identified 90% of
subjects with adenomas or cancers measuring 10 mm or more in diameter. These findings augment published data on the role of CT colonography in screening patients with
an average risk of colorectal cancer. (ClinicalTrials.gov number, NCT00084929; American College of Radiology Imaging Network [ACRIN] number, 6664.)
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C

olorectal cancer is the third most
common cancer and the second leading
cause of death from cancer in the United
States, with an estimated 154,000 new cases and
52,000 deaths in 2007.1 There is an enormous
opportunity to save lives with broadly applied,
widely accepted early-detection programs, since
the natural history of colorectal cancer permits
the recognition and curative treatment of both
precursor adenomas and localized cancers. According to data from multiple sources, mortality
from colorectal cancer is reduced with regular
screening.1-3 Despite its effectiveness, colorectalcancer screening remains underused for many
reasons, including drawbacks in terms of the performance, comfort, availability, and expense of
currently endorsed test options.
Computed tomographic (CT) colonography uses
advanced visualization technology that permits a
minimally invasive, structural evaluation of the
entire colorectum. It has several potential advantages over other screening tests for colorectal
cancer, including rapid imaging of the entire colorectum; a relatively noninvasive technique, with
no need for sedation; and a low risk of procedurerelated complications.4,5
The degree to which CT colonography is effective in detecting asymptomatic colorectal lesions
remains a controversial topic, perhaps in part because of differences in patient populations, imaging protocols, and radiologists’ qualifications in
prior studies. The National CT Colonography Trial
of the American College of Radiology Imaging
Network was designed to assess the accuracy of
CT colonography in detecting histologically confirmed, large colorectal adenomas and cancers
(≥10 mm in diameter), with optical colonoscopy
(the current clinical standard for colorectal cancer screening) and histologic review used as the
reference standard.

Me thods
A total of 15 clinical sites participated in the study,
which complied with the provisions of the Health
Insurance Portability and Accountability Act, and
approval was obtained from the institutional review board at each site. Participants were recruited
from among all asymptomatic patients 50 years of
age or older who were scheduled to undergo routine colonoscopy at the participating sites between
February 2005 and December 2006. Patients were
1208
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excluded from the study if they had had melena or
hematochezia on more than one occasion in the
previous 6 months; if they had lower abdominal
pain, inflammatory bowel disease or familial polyposis syndrome, or a serious medical condition associated with an increased risk of complications
from colonoscopy; if they had undergone colonoscopy in the preceding 5 years; or if they had anemia (a hemoglobin level of less than 10 g per deciliter) or a positive result on a fecal occult-blood test.
Each study participant provided written informed
consent before enrollment.
Radiologist Training

Each participating radiologist was required to submit confirmation of having interpreted at least
500 CT colonographic examinations or having participated in a specialized 1.5-day training session
on CT colonography. In addition, all participating
radiologists were required to complete a qualifying
examination in which they achieved a detection
rate of 90% or more for polyps measuring 10 mm
or more in diameter in a reference image set. Of 20
radiologists who met the initial entry criteria, the
15 with the highest scores on the qualifying examination were subsequently invited to participate
in the study. Details regarding the credentialing
process have been reported previously.6
CT Colonography

The preparation for CT colonography included stool
tagging, laxative purgation, and fluid tagging (see
the Supplementary Appendix, available with the
full text of this article at www.nejm.org). Colonic
insufflation was obtained with an automated carbon dioxide insufflator (PROTOC02L, E-Z-EM).
Manual insufflation with room air was used if adequate colon distention could not be obtained with
the mechanical insufflator. One milligram of subcutaneous glucagon was administered 7 to 15 minutes before the examination unless contraindicated
or declined by the study participant.
Data were obtained with patients in the supine
and prone positions. All examinations were performed with multidetector-row CT scanners that
had a minimum of 16 rows. Images were acquired
with the following specifications: collimation,
0.5 to 1.0 mm; pitch, 0.98 to 1.5; matrix, 512 by
512; field of view to fit the patient, 50 effective
mAs; and peak voltage, 120 kV. A standard reconstruction algorithm was used. Images obtained
with patients in the prone and supine positions
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were reconstructed to slice thicknesses of 1.0
to 1.25 mm, with a reconstruction interval of
0.8 mm.7
The study data were randomly assigned to be
read independently with the use of either a primary two-dimensional search method (conventional two-dimensional image display with threedimensional endoluminal problem solving) or a
primary three-dimensional search method (including the capability of displaying multiplanar twodimensional images). For each abnormality, the
location and size were noted, as well as the radiologist’s degree of confidence that the lesion was
a polyp. The determination of size was based on
two-dimensional images and use of the greatest
diameter. The radiologist’s confidence that each
finding was a polyp was rated on a scale of 0 (not
a lesion) to 5 (high confidence). The radiologists
made their interpretations without knowledge of
the colonoscopic results and were instructed to
record only lesions measuring 5 mm or more in
diameter.
Colonoscopy

After the CT colonographic examination, index
colonoscopy was performed according to the standard clinical protocol at each participating site.
Same-day CT colonographic and colonoscopic examinations were performed for 2512 of 2531 (99%)
participants. Identified lesions were photographed
during the withdrawal phase. Withdrawal times
were not included, since these data were not routinely available from colonoscopic reports. All index colonoscopic examinations were performed or
directly supervised by an experienced endoscopist
(staff gastroenterologist or surgeon) without prior knowledge of the CT colonographic results. For
cases in which lesions that were 10 mm or more
in diameter were detected on CT colonography but
not on colonoscopy, patients were advised to undergo an additional colonoscopic examination
within 90 days; endoscopists were provided with
the CT colonographic results before the colonoscopy was repeated.
Histologic Review and Lesion Matching

Tissue samples from all lesions measuring 5 mm
or more were centrally reviewed by one of the authors, an experienced gastrointestinal pathologist,
and these data were used for all analyses of histologic findings. Adenomas were defined as polyps with cytologic dysplasia involving the epithen engl j med 359;12

lium at the luminal surface and extending to any
crypt depth or as polyps that met the criterion of
aberrant proliferation (sessile serrated adenomas,
as defined by Li and Burgart8 and by Torlakovic
et al.9). Hyperplastic polyps were defined as polyps having a serrated architecture, with no superficial epithelial hyperchromasia and without the
proliferative, full-thickness mucosal changes that
characterize sessile serrated adenoma.
In accordance with prior studies,10,11 lesion size
was determined from the pathology report, unless
the lesion was resected piecemeal, fulgurated, or
not removed, in which case colonoscopy-derived
estimates of size were used. Two of the authors,
both experienced radiologists who had not been
involved in initial lesion detection, matched the
lesions found on CT colonography and colonoscopy on the basis of an established algorithm that
incorporated the location of the lesion (within one
colonic segment) and its size (within 50% of its
reference standard measure).10,12,13 Lesion matching was also evaluated electronically with the use
of the same algorithm. Discrepancies in the results
of the lesion-matching analyses were adjudicated
by these radiologists. If they could not reach a
consensus, the case in question was reviewed by
one of the authors, an experienced gastroenterologist, for final determination of match status.
Statistical Analysis

The results of colonoscopy (including a second
colonoscopy, when performed) and pathological
examination of tissue specimens were the reference
standard for determining lesion size, location, and
histologic type. A positive result on CT colonography was defined as identification of a lesion
measuring 5 mm or more in diameter. If the result of CT colonography was positive and one or
more lesions that met the criteria for size (i.e.
≥10 mm or 6 to 9 mm) were identified with the
use of the reference standard, the CT colonographic result was considered to be a true positive result for a lesion in that size range. If the result of
CT colonography was positive but no lesions of
the appropriate size were found on the reference
standard, the colonography result was considered
a false positive result for lesions in that size range.
The usefulness of CT colonography as a screening
tool was assessed in accordance with per-patient
accuracy.
To reflect community practice, we averaged the
results among radiologists.10,13-15 The per-patient
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sensitivity, specificity, positive predictive value, and
negative predictive value were first estimated for
each radiologist, and then the average values
among the radiologists were calculated.16
Sensitivity, for each radiologist, was calculated
as the proportion of patients with lesions that were
larger than or equal to the prespecified threshold and that were detected on both colonoscopy
and CT colonography. One minus the sensitivity
is equal to the false negative rate for CT colonography and estimates the proportion of patients
with lesions detected on optical colonoscopy that
were missed on CT colonography for each radiologist. Specificity, for each radiologist, was calculated as the proportion of patients who did not
have lesions larger than the prespecified threshold on colonoscopy as well as CT colonography.
One minus the specificity is equal to the false
positive rate for CT colonography and estimates
the proportion of patients whose test results were
negative on optical colonoscopy but positive on
CT colonography for each radiologist. The positive predictive value was calculated as the proportion of patients with CT colonographic findings that were also seen on colonoscopy, and the
negative predictive value was calculated as the proportion of patients with no CT colonographic
findings larger than the prespecified threshold
that were not detected on colonoscopy.
Exact 95% confidence intervals were calculated
for each radiologist, and large-sample 95% confidence intervals were calculated for overall estimates, with the use of standard errors that allowed
for estimation of variation among radiologists. The
sample size was calculated to provide a sufficient
number of patients with at least one histologically
confirmed adenoma or cancer measuring 10 mm
or more in diameter on colonoscopy to ensure
that for anticipated values of sensitivity, the standard error of the average sensitivity among radiologists was less than 0.05 when that standard
error allowed for anticipated variation in sensitivity among radiologists. Receiver-operating-characteristic (ROC) curves were estimated with the
use of data pooled from the radiologists because
of the small number of positive cases reviewed by
each radiologist. Similar analyses were also performed for per-polyp sensitivities and for the identification of patients with any abnormal lesions
measuring 10 mm or more — that is, analyses
were not limited to adenomatous lesions. Per-polyp

1210
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sensitivity was calculated as the percentage of lesions greater than or equal to the prespecified
threshold size that were detected on colonoscopy
and that matched the findings on CT colonography
with the use of the algorithm described above.
Estimates of sensitivity, specificity, negative
predictive value, and positive predictive value were
obtained for patients at increased risk for colorectal cancer because of familial or personal history
as well as for patients at average risk. In addition,
sensitivities were calculated for two-dimensional
and three-dimensional search methods, for different types of bowel preparation, and for differences
in the overall quality of preparation. Because of
the small number of positive cases each radiologist reviewed for these subgroup analyses, only
pooled estimates for sensitivity were calculated,
and uncertainty in estimates was quantified with
the use of exact 95% confidence intervals.

R e sult s
The total number of participants enrolled was
2600 (2617 registrations and 17 duplicates). Complete CT colonographic and colonoscopic results
were available for 2531 participants (97%), which
constituted the study data set (see the Supplementary Appendix). Demographic data are provided
in Table 1. The majority of the participants (89%)
had no known risk factors for colorectal cancer
other than age. There were 235 participants (9%)
who had a first-degree relative with a history of
colorectal polyps or cancer, 34 (1%) who had a
personal history of polyps or cancer, and 13 (<1%)
who had both. All others were considered to be
at average risk for colorectal cancer. The baseline
demographic characteristics of the final cohort
were similar to those of all eligible participants.
Per-Patient Assessment

The overall diagnostic performance of CT colonography in detecting at least one lesion (adenoma or
cancer) measuring 5 mm or more in diameter is
shown in Table 2. The mean (±SD) sensitivity,
specificity, positive predictive value, negative predictive value, and area under the ROC curve
(AUC) for lesions measuring 10 mm or more were
0.90±0.031, 0.86±0.022, 0.23±0.020, 0.99±0.002,
and 0.89±0.020, respectively. Our estimate of a
sensitivity of 0.90 for identifying patients with
large lesions was based on the following calcula-
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Table 1. Characteristics of the Study Participants Overall and According to the Size of Reported Colorectal Neoplasms.*
No Cancer
or Adenoma ≥5 mm
(N = 2249)

Characteristic

Cancer or
Adenoma ≥5 mm
and <10 mm
(N = 173)

Cancer or
Adenoma ≥10 mm
(N = 109)

Total
(N = 2531)

Age at enrollment — yr
Mean

58.0

59.6

60.8

58.3

52–62

53–65

54–66

52–62

Male

1036 (46)

108 (62)

61 (56)

1205 (48)

Female

1213 (54)

65 (38)

48 (44)

1326 (52)

Interquartile range
Sex — no. (%)

Race or ethnic group — no.†
American Indian or Alaskan Native

18

2

3

23

Asian

55

4

0

59

Black

295

24

14

333

7

0

0

7

1856

142

93

2091

42

2

2

46

Native Hawaiian or other Pacific
Islander
White
Unknown or missing
Hispanic or Latino ethnicity — no. (%)
No

2156 (96)

170 (98)

104 (95)

2430 (96)

Yes

89 (4)

3 (2)

5 (5)

97 (4)

0

0

Unknown

4 (<1)

4 (<1)

Medical history of polyps or colon
cancer — no. (%)
10 (9)

235 (9)

Personal history

Family history

213 (9)
30 (1)

12 (7)
1 (<1)

3 (3)

34 (1)

Both family and personal history

13 (<1)

0

0

13 (<1)

* Percentages may not sum to 100 because of rounding.
† Race or ethnic group was self-reported; more than one race or ethnic group may have been reported by a single par
ticipant.

tion: of the 1 to 13 patients who were seen by each
radiologist and who had one or more large lesions
that were detected on optical colonoscopy, CT
colonography detected large lesions in 90% of
patients on average; this indicates that for 10% of
patients with one or more large lesions detected
by colonoscopy, CT colonography did not detect
a large lesion. The sensitivity for the detection of
adenomas or cancers greater than or equal to
5 mm, 6 mm, 7 mm, 8 mm, and 9 mm was 0.65,
0.78, 0.84, 0.87, and 0.90, respectively, with specificity ranging from 0.86 to 0.89. The sensitivity,
specificity, positive predictive value, and negative
predictive value were similar for participants at
increased risk for colorectal cancer and for those

n engl j med 359;12

at average risk. Estimates of the sensitivity for individual radiologists are shown in Figure 1. Sensitivity ranged from 0.67 to 1.00, with 7 of 15
radiologists (47%) identifying all the patients
with large lesions. For identification of patients
with lesions regardless of histologic type, the estimates of sensitivity, specificity, positive predictive value, negative predictive value, and AUC were
0.87±0.035, 0.86±0.022, 0.28±0.026, 0.99±0.002,
and 0.88±0.019, respectively.
The distribution, histologic type, and size of
the lesions found on colonoscopy are listed in Table 3. There were 128 large adenomas or carcinomas in 109 of the 2531 patients (4%). Seven adenocarcinomas in seven patients were 10 mm or
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No. of patients

2249

No. of patients

n engl j med 359;12
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2531

2531

0.84 (0.810–0.878)

2531

0.87 (0.833–0.902)

2108

2531

0.88 (0.842–0.913)

2108

0.99 (0.984–0.994)

423

0.31 (0.256–0.355)

2377

0.87 (0.825–0.909)

154

2531

0.89 (0.853–0.930)

2108

0.99 (0.990–0.998)

423

0.25 (0.209–0.292)

2411

0.86 (0.817–0.902)

120

0.90 (0.83–0.96)

≥9 mm

2531

0.89 (0.854–0.933)

2108

0.99 (0.991–0.998)

423

0.23 (0.194–0.273)

2422

0.86 (0.813–0.900)

109

0.90 (0.84–0.96)

≥10 mm

* Values for detection of lesions on CT colonography were averaged among radiologists. Sensitivity indicates the proportion of patients who had lesions (of the specified size) detected
on optical colonoscopy that were also detected on CT colonography. Specificity indicates the proportion of patients who had no lesions detected on optical colonoscopy or on CT
colonography. Positive predictive value indicates the proportion of patients with CT colonographic findings (of the specified size) that were also detected on optical colonoscopy.
Negative predictive value indicates the proportion of patients with no lesions of the specified size detected on CT colonography who also had no lesions detected on optical colonoscopy. The receiver-operating-characteristic (ROC) curve plots sensitivity versus the false positive rate, and the area under the ROC curve represents the accuracy of CT colonography.

0.80 (0.763–0.828)

No. of patients

2108

0.99 (0.980–0.992)

423

0.35 (0.299–0.397)

2357

0.87 (0.831–0.914)

174

0.87 (0.80–0.93)

≥8 mm

of

Value (95% CI)

2108

0.98 (0.971–0.984)

423

0.40 (0.335–0.463)

2321

0.88 (0.840–0.920)

210

0.84 (0.78–0.91)

≥7 mm

Size of Adenoma or Cancer Detected on Optical Colonoscopy

0.78 (0.71– 0.85)

≥6 mm

n e w e ng l a n d j o u r na l

Area under ROC curve

No. of patients

Value (95% CI)

0.95 (0.941–0.965)

423

No. of patients

Negative predictive value

0.45 (0.389–0.513)

Value (95% CI)

Positive predictive value

0.89 (0.851–0.923)

Value (95% CI)

Specificity

0.65 (0.58–0.73)

≥5 mm

Value (95% CI)

Sensitivity

Performance Measure

Table 2. Estimated Per-Patient Accuracy in Detecting Adenomas or Cancers on CT Colonography.*
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more in diameter. A total of 547 lesions measuring 5 mm or more in diameter were detected.
Nonadenomatous lesions included 136 hyperplastic polyps (25%), 7 lipomas (1%), and 30 lesions
with other histologic features (5%).
The sensitivity of CT colonography for the detection of lesions of various sizes is shown in Table 4
for the overall study population. The overall sensitivity estimate for the detection of large lesions
was 0.84±0.043.

0.8

Sensitivity

Per-Polyp Assessment

1.0

Colon Preparation

Polyethylene glycol solution was used for colon
preparation in 1020 of the 2531 participants (40%),
sodium phosphate solution in 1403 (55%), magnesium citrate in 102 (4%), and other substances
in 6 (<1%). Barium sulfate for fecal tagging and
n engl j med 359;12

0.6

6
5

5

10

9

0.4

0.2

2

0.0 1
1

2

10

8

4
11

6

Assessment of Missed Lesions

The median size of neoplasms (≥5 mm in diameter
by study design) that were detected and those that
were missed on CT colonography was 10 mm and
6 mm, respectively. There was no association between undetected polyps and their location or histologic type. A single 10-mm cancer in the low
rectum was missed on CT colonography. This lesion was not visible on a second review.
A total of 30 lesions measuring 10 mm or more
were detected in 27 participants on CT colonography but were not detected on the initial colonoscopy. Fifteen of these 27 participants, with 18
reported lesions, returned for a second colonoscopy, as called for by the protocol. Five of 18 lesions were confirmed on the second colonoscopy
(considered to be true positive CT colonographic
findings). The diameters of these five lesions
were 9 mm (inflammatory polyp), 10 mm (tubular adenoma), 11 mm (tubular adenoma), 14 mm
(inflammatory polyp), and 35 mm (tubulovillous
adenoma with dysplasia); they were polypoid and
located in five different segments. Confirmatory
colonoscopy was not performed for the remaining 12 patients. Three patients had findings that
did not warrant the recall (one surgical hemicolectomy, one benign stricture, and one instance in
which the CT colonographic finding was discounted by the colonoscopist), three patients declined
to return, and six patients did not return because
the referring physician determined that the recall
was not warranted.

109

13

13

6

3

4

5

6

7

8

9

10 11 12 13 14 15 Average

Radiologist Number

Figure 1. Individual Estimates of the Sensitivity of CT Colonography
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iodinated contrast material for fluid tagging were
taken as directed by 2482 (98%) and 2390 (94%)
of the participants, respectively. Glucagon was administered in 2328 (92%) participants. Glucagon
was not given to 78 participants with brittle diabetes, 1 participant with a borderline glucose level, 2 with pheochromocytoma, 69 who declined,
47 for whom the drug was unavailable, and 6 for
whom a physician was not available during administration.
Imaging

CT colonographic examinations were performed
on 16-slice scanners in 1140 patients (45%), 40slice scanners in 83 patients (3%), and 64-slice
scanners in 1308 patients (52%). Radiologists made
1280 interpretations using primary two-dimensional interpretation with three-dimensional problem solving and 1251 interpretations using primary three-dimensional endoluminal fly-through
with two-dimensional problem solving. The CT
colonographic software used for interpretation included Vital Images (Innerview GI), General Elec-
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Table 3. Distribution of Lesions Detected on Optical Colonoscopy According to Location, Histologic Type, and Size.*
Segment and Histologic Type

No. of Lesions Detected†
5–9 mm

≥10 mm

Total

Adenoma or carcinoma

25

25

50

Nonadenomatous lesion

33

7

40

Adenoma or carcinoma

62

32

94

Nonadenomatous lesion

49

4

53

Adenoma or carcinoma

32

8

40

Nonadenomatous lesion

16

2

18

Adenoma or carcinoma

52

17

69

Nonadenomatous lesion

22

4

26

Adenoma or carcinoma

47

27

74

Nonadenomatous lesion

16

7

23

Adenoma or carcinoma

28

19

47

Nonadenomatous lesion

10

3

13

Adenoma or carcinoma

246

128

374

Nonadenomatous lesion

146

27

173

Rectum

Sigmoid

Descending

Transverse

Ascending

Cecum

Total

* A total of seven lesions measuring 5 mm or more in diameter were malignant (two were 10 mm, one was 15 mm, two
were 25 mm, one was 55 mm, and one was 100 mm); there were three in the rectum and one each in the sigmoid, descending, and transverse colon and the cecum. One malignant lesion measuring 10 mm was not seen on CT colonography. Thirteen adenomas, all measuring ≥10 mm (nine were 10 mm, one was 11 mm, two were 16 mm, and one was
25 mm), were not seen on CT colonography.
† A total of 1629 of the 2531 participants had no polyps of any size; 2141 had no polyps that were 5 mm or more in diameter; 512 had at least one polyp, with the largest being <5 mm. Data in the table represent the 258 participants with
polyps measuring 5 to 9 mm and the 132 with polyps ≥10 mm. The mean (±SD) diameter of polyps measuring at least
5 mm was 8.9±7.2 mm. Size measurements from colonoscopy were used for 333 (61%) of 547 polyps because the polyps were removed in pieces.

tric (Advantage CTC), Siemens (Syngo Colonography), Viatronix (V3D:), and TeraRecon (Aquarius
Workstation).
The pooled sensitivities for detecting large lesions with the use of primary two-dimensional
conventional software and primary three-dimensional endoluminal fly-through software were
similar: 0.87 (95% confidence interval [CI], 0.75
to 0.95) and 0.88 (95% CI, 0.76 to 0.95), respectively. The difference between the two types of
viewing software was not significant. The mean
time was 19.4 minutes for the primary two-dimensional interpretation, as compared with 25.3 min1214

n engl j med 359;12

utes for the primary three-dimensional interpretation. There was no correlation between the
number of cases interpreted and the radiologist’s
performance (Fig. 1).
Adverse Events

Adverse events (grade 3 or higher) were reported
in three participants (severe nausea and vomiting
for less than 24 hours after CT colonography in
one participant; hematochezia after snare polypectomy, requiring 2 days of hospitalization, in one;
and hospitalization for Escherichia coli bacteremia
24 hours after both procedures in one).
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Table 4. Per-Polyp Analysis of the Sensitivity of CT Colonography for the Detection of Adenomas and Cancers.*
Sensitivity
Value
No. of lesions

Size of Adenoma or Cancer
≥5 mm

≥6 mm

≥7 mm

≥8 mm

≥9 mm

≥10 mm

0.59±0.045

0.70±0.046

0.75±0.042

0.80±0.041

0.82±0.042

0.84±0.043

374

270

220

187

143

128

* Plus–minus values are means ±SE. Values for detection of lesions on CT colonography were averaged among radiologists. The sensitivity is the proportion of lesions (of the specified size) detected on optical colonoscopy that were
matched through a lesion-matching algorithm on CT colonography. Lesion sizes were determined by the reference
standard (pathological examination of tissue specimens or colonoscopic estimate).

Extracolonic Findings

Extracolonic findings were observed in 66% of
the participants; however, only 16% were deemed
to require either additional evaluation or urgent
care. These findings were located in the chest
(27%), gastrointestinal tract (18%), genitourinary
tract (45%), vascular system (6%), and musculoskeletal system (3%).

Discussion
In our study, CT colonography identified 90% of
patients with asymptomatic large colorectal adenomas or cancers (≥10 mm in diameter) that were
detected by optical colonoscopy, with an AUC of
0.89. Secondary analyses showed that CT colonography had a lower sensitivity for smaller colorectal lesions (6 to 9 mm).
Our estimates of the sensitivity of CT colonography for detecting lesions found on colonoscopy
are higher than estimates in some other stu
dies.10,13,14 Pickhardt et al. reported results similar to ours.12 Although the higher accuracy in the
study by Pickhardt et al. than in other studies has
been attributed by some to use of a primary threedimensional endoluminal reading technique, our
study showed similar performance with the two
image-display methods and all software brands
used, with the primary three-dimensional technique requiring nearly 6 additional minutes (a 23%
increase in time) for interpretation as compared
with the primary two-dimensional technique.
The main objective of this prospective trial was
to evaluate the screening-performance characteristics of CT colonography with the use of optimized, yet reproducible, image acquisition and
interpretation methods in a diverse, multicenter
setting and to compare these observations with
findings on screening colonoscopy and histologic
review, the reference standard. To maximize the

n engl j med 359;12

likelihood that the colonoscopic data reflected
usual clinical practice, we intentionally avoided
incorporating advanced endoscopist training (beyond usual credentialing requirements) and nonstandard examination techniques (e.g., segmental
unblinding) into our study design. Since undetected-adenoma rates of 2% and 13% for polyps
10 mm or larger and polyps 5 mm or larger, respectively, have been reported in tandem colonoscopic studies,17 the CT colonographic performance characteristics reported in our trial may
actually be underestimated. The specificity estimate for large lesions in our study was lower than
that in other multi-institutional studies.12-14 This
may be due to the training sessions, which emphasized polyp detection (maximizing sensitivity),
and may be a potential weakness of the training
process. This trial required all radiologists to be
trained on at least 50 CT colonographic cases before demonstrating the minimal level of competence. Most of the radiologists in our trial were
required to obtain training beyond the initial 50
cases to recognize lesions that are difficult to
detect.
Like other recent prospective CT colonographic
screening studies,10,12-14 our study focused on lesions measuring 5 mm or more, since the prevalence of advanced histologic features in small
polyps (i.e., <5 mm) is reportedly below 2%.18
Specificity estimates can be improved if the minimum size threshold for a radiologic finding is
increased. According to the reference standard,
the overall prevalence of large adenomas and cancers in this population was 4%. If all patients with
a lesion measuring 5 mm or more on CT colonography were to be referred for colonoscopy, the
colonoscopy-referral rate, based on our results,
would be 17%. If a 6-mm threshold were used
instead, the referral rate would drop to 12%. With
an increase in the size threshold for radiologic
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findings to 6 mm, specificity would increase to
0.91, with little decrease in sensitivity (to 0.88)
for large adenomas.
Extracolonic abnormalities identified in this
study were similar to those reported in previous
studies.19-24 Further definition of interdisciplinary management algorithms for these findings is
needed to optimize the public health benefit from
CT colonographic screening.
Despite the consensus opinion that colorectal
cancer screening is effective,2,3 adherence to current guidelines remains low among adults eligible
for screening.25 Guidelines for colorectal-cancer
screening support multiple test options so that
patients and providers can work together to determine their preferred method of examination.
The less invasive nature of CT colonography and
the low risk of procedure-related complications,
as compared with colonoscopy, may be attractive
to patients and may improve screening-adherence
rates by addressing certain concerns of both patients and providers.
In summary, this large, multicenter study of
asymptomatic adults showed that CT colonographic screening identified 90% of patients with
adenomas and cancers measuring 10 mm or more
in diameter. These findings support and extend
previously published data regarding the role of CT
colonography in screening patients with an average risk of colorectal cancer.
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